Insulin-like growth factors
- PMID: 1307923
- DOI: 10.1159/000109323
Insulin-like growth factors
Abstract
The insulin-like growth factors (IGF-I and IGF-II) play important roles in the regulation of growth and metabolism. While the liver is the main source of circulating IGFs, their production by numerous extrahepatic tissues suggests the existence of autocrine and paracrine modes of action in addition to typical endocrine mechanisms. The actions of the IGFs are mediated through their activation of specific cell surface receptors, primarily the IGF-I receptor, although some effects may be mediated through the IGF-II receptor and the insulin receptor. The stability of the IGFs and their interaction with their receptors are mediated by specific IGF binding proteins (IGF-BPs) which are found in the circulation and in extracellular fluids. Thus, the overall biological actions of the IGFs can be regulated by control of ligand biosynthesis, modulation of receptor levels and postreceptor signalling pathways, and changes in the levels and activity of IGF-BPs.
Similar articles
-
Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.Cancer Res. 1993 Oct 1;53(19):4680-5. Cancer Res. 1993. PMID: 7691401
-
Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.Endocrinology. 1997 Oct;138(10):4390-400. doi: 10.1210/endo.138.10.5265. Endocrinology. 1997. PMID: 9322955
-
Role of the insulin-like growth factors in the endocrine control of glucose homeostasis.Diabetes Res Clin Pract. 1994 Feb;23(1):3-15. doi: 10.1016/0168-8227(94)90121-x. Diabetes Res Clin Pract. 1994. PMID: 7516850 Review.
-
Insulin-like growth factor-I resistance.Endocr Rev. 1998 Oct;19(5):625-46. doi: 10.1210/edrv.19.5.0348. Endocr Rev. 1998. PMID: 9793761 Review. No abstract available.
-
Insulin-like growth factors in endometrial function.Gynecol Endocrinol. 1998 Dec;12(6):399-406. doi: 10.3109/09513599809012842. Gynecol Endocrinol. 1998. PMID: 10065165 Review.
Cited by
-
The effects of fluoxetine treatment in a chronic mild stress rat model on depression-related behavior, brain neurotrophins and ERK expression.J Mol Neurosci. 2011 Oct;45(2):246-55. doi: 10.1007/s12031-011-9515-5. Epub 2011 Apr 9. J Mol Neurosci. 2011. PMID: 21479508
-
Polycystic ovary syndrome in the pediatric population.Metab Syndr Relat Disord. 2010 Oct;8(5):375-94. doi: 10.1089/met.2010.0039. Metab Syndr Relat Disord. 2010. PMID: 20939704 Free PMC article. Review.
-
Growth Factor Engineering Strategies for Regenerative Medicine Applications.Front Bioeng Biotechnol. 2020 Jan 21;7:469. doi: 10.3389/fbioe.2019.00469. eCollection 2019. Front Bioeng Biotechnol. 2020. PMID: 32039177 Free PMC article. Review.
-
Proteomic profiling differences in serum from silicosis and chronic bronchitis patients: a comparative analysis.J Thorac Dis. 2016 Mar;8(3):439-50. doi: 10.21037/jtd.2016.02.68. J Thorac Dis. 2016. PMID: 27076939 Free PMC article.
-
Intrathecal IGF2 siRNA injection provides long-lasting anti-allodynic effect in a spared nerve injury rat model of neuropathic pain.PLoS One. 2021 Dec 2;16(12):e0260887. doi: 10.1371/journal.pone.0260887. eCollection 2021. PLoS One. 2021. PMID: 34855889 Free PMC article.